Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Growth hormone evaluation in Duchenne muscular dystrophy.

Literature DB >> 3215748

Growth hormone evaluation in Duchenne muscular dystrophy.

L Merlini¹, C Granata, A Ballestrazzi, F Cornelio, P Tassoni, S Tugnoli, E Cacciari.

Abstract

Growth hormone (GH) release with pharmacological tests and sleep test, somatomedin C and auxological features were studied in 10 patients affected by Duchenne Muscular Dystrophy. GH release in these patients seems to be lower than normal; moreover some of them are of short stature without an evident relationship with GH deficit. The possible significance of the data obtained is discussed, particularly in relation to the clinical course of the disease, and to current therapeutic trials with a GH release inhibitor (mazindol).

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 1988 PMID： 3215748 DOI： 10.1007/bf02337165

Source DB: PubMed Journal: Ital J Neurol Sci ISSN： 0392-0461

15 in total

1. Management of progressive muscular dystrophy in childhood.

Authors: P J VIGNOS; G E SPENCER; K C ARCHIBALD
Journal: JAMA Date: 1963-04-13 Impact factor: 56.272

2. [Dynamic exploration of the antehypophysis in the child].

Authors: A Cicognani; P Pirazzoli; F Bernardi; S Salardi; F Zuppulla; S Zingoni; P Tassoni; E Cacciari
Journal: Minerva Pediatr Date: 1975-04-21 Impact factor: 1.312

3. Benign Duchenne muscular dystrophy in a patient with growth hormone deficiency: a five years follow-up.

Authors: M Zatz; R T Betti
Journal: Am J Med Genet Date: 1986-07

4. Human growth hormone in myopathy: myotonic dystrophy, duchenne muscular dystrophy, and limb-girdle muscular dystrophy.

Authors: S B Chyatte; D Rudman; J H Patterson; P Ahmann; A Jordan
Journal: South Med J Date: 1974-02 Impact factor: 0.954

5. Suggestion for a possible mitigating treatment of Duchenne muscular dystrophy.

Authors: M Zatz; O Frota-Pessoa
Journal: Am J Med Genet Date: 1981

6. Benign Duchenne muscular dystrophy in a patient with growth hormone deficiency.

Authors: M Zatz; R T Betti; J A Levy
Journal: Am J Med Genet Date: 1981

7. Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.

Authors: M Zatz; R T Betti; O Frota-Pessoa
Journal: Am J Med Genet Date: 1986-07

8. Hypophysectomy mitigates skeletal muscle fiber damage in hamster dystrophy.

Authors: G Karpati; P Jacob; S Carpenter; S Prescott
Journal: Ann Neurol Date: 1985-01 Impact factor: 10.422

9. Growth hormone release during sleep in growth-retarded children with normal response to pharmacological tests.

Authors: E Cacciari; G Coccagna; A Cicognani; P Pirazzoli; R Gallassi; P Farneti; F Bernardi; F Zappulla; G Gobbi; P Verucchi
Journal: Arch Dis Child Date: 1978-06 Impact factor: 3.791

10. Growth hormone inhibition causes increased selenium levels in Duchenne muscular dystrophy: a possible new approach to therapy.

Authors: P J Collipp; J Kelemen; S Y Chen; M Castro-Magana; M Angulo; A Derenoncourt
Journal: J Med Genet Date: 1984-08 Impact factor: 6.318

4 in total

4. Retrospective cohort study comparing the efficacy of prednisolone and deflazacort in children with muscular dystrophy: A 6 years' experience in a South Indian teaching hospital.

Authors: Harish Petnikota; Vrisha Madhuri; Sangeet Gangadharan; Indira Agarwal; Belavendra Antonisamy
Journal: Indian J Orthop Date: 2016-09 Impact factor: 1.251